Emmessar Biotech And Nutrition (BOM:524768) Book Value per Share : ₹15.43 (As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Emmessar Biotech And Nutrition Book Value per Share?

Emmessar Biotech And Nutrition's book value per share for the quarter that ended in Mar. 2025 was ₹15.43.

During the past 12 months, Emmessar Biotech And Nutrition's average Book Value Per Share Growth Rate was 4.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 7.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 11.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 22.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Emmessar Biotech And Nutrition was 56.80% per year. The lowest was -22.50% per year. And the median was 9.40% per year.

Emmessar Biotech And Nutrition's current price is ₹34.93. Its book value per share for the quarter that ended in Mar. 2025 was ₹15.43. Hence, today's PB Ratio of Emmessar Biotech And Nutrition is 2.26.

During the past 13 years, the highest P/B Ratio of Emmessar Biotech And Nutrition was 12.83. The lowest was 1.21. And the median was 2.66.

Good Sign:

Emmessar Biotech And Nutrition Ltd stock PB Ratio (=2.24) is close to 1-year low of 2.07.

Emmessar Biotech And Nutrition Book Value per Share Historical Data

The historical data trend for Emmessar Biotech And Nutrition's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emmessar Biotech And Nutrition Book Value per Share Chart

Emmessar Biotech And Nutrition Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Book Value per Share

Get a 7-Day Free Trial

11.41

12.35

13.34

14.82

15.43

Emmessar Biotech And Nutrition Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Book Value per Share	Get a 7-Day Free Trial															14.82	-	15.55	-	15.43

Competitive Comparison of Emmessar Biotech And Nutrition's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Emmessar Biotech And Nutrition's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emmessar Biotech And Nutrition's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emmessar Biotech And Nutrition's PB Ratio distribution charts can be found below:

* The bar in red indicates where Emmessar Biotech And Nutrition's PB Ratio falls into.

Save Embed

;

Save Embed

;

Emmessar Biotech And Nutrition Book Value per Share Calculation

Emmessar Biotech And Nutrition's Book Value Per Share for the fiscal year that ended in Mar. 2025 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(77.08	-	0.00)	/	5.00
	=	15.43

Emmessar Biotech And Nutrition's Book Value Per Share for the quarter that ended in Mar. 2025 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(77.08	-	0.00)	/	5.00
	=	15.43

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Emmessar Biotech And Nutrition (BOM:524768) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Emmessar Biotech And Nutrition Book Value per Share Related Terms

Thank you for viewing the detailed overview of Emmessar Biotech And Nutrition's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Emmessar Biotech And Nutrition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emmessar Biotech And Nutrition Ltd (BOM:524768) » Definitions » Book Value per Share

Traded in Other Exchanges

N/A

Address

38, Cawasji Patel Street, 29, Kamer Building, 4th floor, Fort, Mumbai, MH, IND, 400001

Website

https://www.ebnl.org

Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.

Emmessar Biotech And Nutrition Headlines

No Headlines